Cite

    Marion Tonneau et al.. “Helicobacter pylori serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors.” Oncoimmunology, vol. 11, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100159167951.0x000007